Blepharitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials

Evaluation of AXR-270 for the Treatment of Posterior Blepharitis Associated With Meibomian Gland Dysfunction
Conditions:   Posterior Blepharitis;   Meibomian Gland Dysfunction Interventions:   Drug: AXR-270 Low Dose;   Drug: AXR-270 High Dose;   Drug: AXR-270 Vehicle Sponsor:   AxeroVision, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2020 Category: Research Source Type: clinical trials